মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

renaissance pharma, inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride 1 mg in 1 g - naftifine hydrochloride cream, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms trichophyton rubrum, trichophyton mentagrophytes, and epidermophyton floccosum. naftifine hydrochloride cream, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride cream usp, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms trichophyton rubrum, trichophyton mentagrophytes, and epidermophyton floccosum . naftifine hydrochloride cream usp, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride gel, 1% is indicated for the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms trichophyton rubrum, trichophyton mentagrophytes, trichophyton tonsurans1 , epidermophyton floccosum1 . 1 efficacy for this organism in this organ system was studied in fewer than 10 infections. naftifine hydrochloride gel, 1% is contraindicated in individuals who have shown hypersensitivity to any of their components.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

xiromed, llc - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride cream is indicated for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism trichophyton rubrum . none risk summary there are no available data with naftifine hydrochloride cream in pregnant women to inform the drug-associated risk for major birth defects and miscarriage.  in animal reproduction studies, no adverse effects on embryofetal development were seen at oral doses administered during the period of organogenesis up to 18 times the maximum recommended human dose (mrhd) in pregnant rats or subcutaneous doses administered during the period of organogenesis up to 2 times the mrhd in pregnant rats or 4 times the mrhd in pregnant rabbits [see data] . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown.  all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and misc

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride cream is indicated for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism trichophyton rubrum . none risk summary there are no available data with naftifine hydrochloride cream in pregnant women to inform the drug-associated risk for major birth defects and miscarriage. in animal reproduction studies, no adverse effects on embryofetal development were seen at oral doses administered during the period of organogenesis up to 18 times the maximum recommended human dose (mrhd) in pregnant rats or subcutaneous doses administered during the period of organogenesis up to 2 times the mrhd in pregnant rats or 4 times the mrhd in pregnant rabbits [see data] . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and misca

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

renaissance pharma, inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride cream, 2% is indicated for the treatment of: interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism trichophyton rubrum . none pregnancy category b. there are no adequate and well-controlled studies of naftifine hydrochloride cream, 2% in pregnant women. because animal reproduction studies are not always predictive of human response, naftifine hydrochloride cream, 2% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. the animal multiples of human exposure calculations were based on daily dose body surface area comparison (mg/m2 ) for the reproductive toxicology studies described in this section and in section 13.1. the maximum recommended human dose (mrhd) was set at 8 g 2% cream per day (2.67 mg/kg/day for a 60 kg individual). systemic embryofetal development studies were conducted in rats and rabbits. oral doses of 30, 100 and 300 mg/kg/day naftifine hydrochloride were administered during the period of o

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride gel usp, 2% is indicated for the treatment of interdigital tinea pedis caused by the organisms trichophyton rubrum , trichophyton mentagrophytes , and epidermophyton floccosum . none. risk summary there are no available data on naftifine hydrochloride gel use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, no adverse effects on embryofetal development were seen at oral doses administered during the period of organogenesis up to 37 times the maximum recommended human dose (mrhd) in pregnant rats or subcutaneous doses administered during the period of organogenesis up to 4 times the mrhd in pregnant rats or 7 times the mrhd in pregnant rabbits (see data ). all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general popul

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

physicians total care, inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine 10 mg in 1 g - naftin® cream, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms trichophyton rubrum, trichophyton mentagrophytes, and epidermophyton floccosum. naftin® cream, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

physicians total care, inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride 10 mg in 1 g - naftin® gel, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms trichophyton rubrum, trichophyton mentagrophytes, trichophyton tonsurans1 and epidermophyton floccosum.1 naftin® gel, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

merz pharmaceuticals, llc - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride 2 g in 100 g